The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen

Too often, seniors who use opioids become targets for exploitation and abuse.

U.S. Seeks to Block Bankruptcy Plan That Would Free Sacklers From Opioid Claims

The Justice Department has been appealing the deal, approved earlier this month.

Opinion | The Use of Antipsychotic Drugs in Nursing Homes

A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.

Opinion | The Sacklers Are Walking Off Into the Sunset. Reform the System.

The Purdue Pharma bankruptcy case settlement protected the wealthy and ignored those who suffered.

Keith McCants, Football Star Laid Low by Drugs, Dies at 53

At one time the N.F.L.’s highest-paid defensive player, he left the league after six seasons and fell into a spiral of addiction, homelessness and desolation.

Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused (Published 2018)

A confidential Justice Department report found the company was aware early on that OxyContin was being crushed and snorted for its powerful narcotic, but continued to promote it as less addictive.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Richard Sackler Says Family and Purdue Bear No Responsibility for Opioid Crisis

In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.

Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from lawsuits related to Purdue Pharma.

States and Cities Near Tentative $26 Billion Deal in Opioids Cases

The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.

15 States Reach a Deal With Purdue Pharma, Advancing a $4.5 Billion Opioids Settlement

The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.

‘On That Edge of Fear’: One Woman’s Struggle With Sickle Cell Pain

Cures for a disease that mostly afflicts Black people seem near but may come too late for Lisa Craig, who lives with an agony like knives stabbing her bones.

Paul J. Hanly Jr., Top Litigator in Opioid Cases, Dies at 70

Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.